Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Fabbri

Showing results (141-150 of 570) with videos related to

Pageof 57
Sort By:
Annals of Allergy|May 1, 1985
Combined asthma and alveolitis due to diphenylmethane diisocyanate (MDI) with demonstration of no crossed respiratory reactivity to toluene diisocyanate (TDI)C E Mapp, L Dal Vecchio, P Boschetto, et al.
The European Respiratory Journal|April 20, 2019
Triple therapy for all patients with severe symptomatic COPD at risk of exacerbationsAlberto Papi, Stefano Petruzzelli, Stefano Vezzoli, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|June 26, 2001
Low domestic exposure to house dust mite allergens (Der p 1) is associated with a reduced non-specific bronchial hyper-responsiveness in mite-sensitized asthmatic subjects under optimal drug treatmentP Maestrelli, L Zanolla, P Puccinelli, et al.
Genetics|April 4, 2006
The effects of mismatch repair and RAD1 genes on interchromosomal crossover recombination in Saccharomyces cerevisiaeAinsley Nicholson, Rebecca M Fabbri, Jason W Reeves, et al.
International Journal of Chronic Obstructive Pulmonary Disease|December 28, 2018
Triple therapy (ICS/LABA/LAMA) in COPD: time for a reappraisalLowie Vanfleteren, Leonardo M Fabbri, Alberto Papi, et al.
The European Respiratory Journal|October 2, 2008
Passive smoking and asthma deathG Invernizzi, R Boffi, A Ruprecht, et al.
Current Drug Targets|December 22, 2012
Inhaled corticosteroids in COPD: pros and consEleftherios Zervas, Konstantinos Samitas, Mina Gaga, et al.
International Journal of Chronic Obstructive Pulmonary Disease|March 19, 2019
Extrafine triple therapy delays COPD clinically important deterioration vs ICS/LABA, LAMA, or LABA/LAMADave Singh, Leonardo M Fabbri, Stefano Vezzoli, et al.
Recenti Progressi in Medicina|May 17, 2006
[New tools for a better diagnosis of latent tuberculosis infection]Giovanni Ferrara, Monica Losi, Pietro Roversi, et al.
Advances in Cancer Research|November 3, 2009
Clusterin (CLU) and lung cancerF Panico, F Rizzi, L M Fabbri, et al.
Pageof 57

Showing results (141-150 of 570) with videos related to

Sort By:
Pageof 57
Annals of Allergy|May 1, 1985
Combined asthma and alveolitis due to diphenylmethane diisocyanate (MDI) with demonstration of no crossed respiratory reactivity to toluene diisocyanate (TDI)C E Mapp, L Dal Vecchio, P Boschetto, et al.
The European Respiratory Journal|April 20, 2019
Triple therapy for all patients with severe symptomatic COPD at risk of exacerbationsAlberto Papi, Stefano Petruzzelli, Stefano Vezzoli, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|June 26, 2001
Low domestic exposure to house dust mite allergens (Der p 1) is associated with a reduced non-specific bronchial hyper-responsiveness in mite-sensitized asthmatic subjects under optimal drug treatmentP Maestrelli, L Zanolla, P Puccinelli, et al.
Genetics|April 4, 2006
The effects of mismatch repair and RAD1 genes on interchromosomal crossover recombination in Saccharomyces cerevisiaeAinsley Nicholson, Rebecca M Fabbri, Jason W Reeves, et al.
International Journal of Chronic Obstructive Pulmonary Disease|December 28, 2018
Triple therapy (ICS/LABA/LAMA) in COPD: time for a reappraisalLowie Vanfleteren, Leonardo M Fabbri, Alberto Papi, et al.
The European Respiratory Journal|October 2, 2008
Passive smoking and asthma deathG Invernizzi, R Boffi, A Ruprecht, et al.
Current Drug Targets|December 22, 2012
Inhaled corticosteroids in COPD: pros and consEleftherios Zervas, Konstantinos Samitas, Mina Gaga, et al.
International Journal of Chronic Obstructive Pulmonary Disease|March 19, 2019
Extrafine triple therapy delays COPD clinically important deterioration vs ICS/LABA, LAMA, or LABA/LAMADave Singh, Leonardo M Fabbri, Stefano Vezzoli, et al.
Recenti Progressi in Medicina|May 17, 2006
[New tools for a better diagnosis of latent tuberculosis infection]Giovanni Ferrara, Monica Losi, Pietro Roversi, et al.
Advances in Cancer Research|November 3, 2009
Clusterin (CLU) and lung cancerF Panico, F Rizzi, L M Fabbri, et al.
Pageof 57